Literature DB >> 9839525

Adenoviral expression of the cyclin-dependent kinase inhibitor p27Kip1: a strategy for breast cancer gene therapy.

A N Rakkar1, Z Li, Y Katayose, M Kim, K H Cowan, P Seth.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9839525     DOI： 10.1093/jnci/90.23.1836

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  4 in total

1.  Inducible expression of a degradation-resistant form of p27Kip1 causes growth arrest and apoptosis in breast cancer cells.

Authors:  Qingxiu Zhang; Ling Tian; Abdel Mansouri; Anita L Korapati; Terry J Johnson; Francois X Claret
Journal:  FEBS Lett       Date:  2005-07-18       Impact factor: 4.124

2.  Antitumor bioactivity of adenovirus-mediated p27mt in colorectal cancer cell line SW480.

Authors:  Ze-Qun Sun; Chang-Sheng Deng; Shao-Yong Xu; Yong Du
Journal:  World J Gastroenterol       Date:  2008-10-14       Impact factor: 5.742

3.  Adenovirus expressing mutant p27kip1 enhanced apoptosis and inhibited the growth of xenografted human breast cancer.

Authors:  Tsuyoshi Sasaki; Yu Katayose; Kuniharu Yamamoto; Masamichi Mizuma; Satoru Shiraso; Shinichi Yabuuchi; Akira Oda; Toshiki Rikiyama; Masaya Oikawa; Toru Onogawa; Masanori Suzuki; Choon-Taek Lee; Michiaki Unno
Journal:  Surg Today       Date:  2007-11-26       Impact factor: 2.549

4.  Decreasing of p27(Kip1)and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer.

Authors:  T Kamai; K Takagi; H Asami; Y Ito; H Oshima; K I Yoshida
Journal:  Br J Cancer       Date:  2001-05-04       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.